These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 37066817)

  • 21. Prognostic significance of cardiac magnetic resonance-based markers in patients with hypertrophic cardiomyopathy.
    Dohy Z; Szabo L; Toth A; Czimbalmos C; Horvath R; Horvath V; Suhai FI; Geller L; Merkely B; Vago H
    Int J Cardiovasc Imaging; 2021 Jun; 37(6):2027-2036. PubMed ID: 33555536
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation of left ventricular dyssynchrony on gated myocardial perfusion SPECT analysis with extent of late gadolinium enhancement on cardiac magnetic resonance imaging in hypertrophic cardiomyopathy.
    Yuki H; Utsunomiya D; Shiraishi S; Takashio S; Sakamoto F; Tsuda N; Oda S; Kidoh M; Nakaura T; Tsujita K; Yamashita Y
    Heart Vessels; 2018 Jun; 33(6):623-629. PubMed ID: 29230571
    [TBL] [Abstract][Full Text] [Related]  

  • 23. How are ECG parameters related to cardiac magnetic resonance images? Electrocardiographic predictors of left ventricular hypertrophy and myocardial fibrosis in hypertrophic cardiomyopathy.
    Dohy Z; Vereckei A; Horvath V; Czimbalmos C; Szabo L; Toth A; Suhai FI; Csecs I; Becker D; Merkely B; Vago H
    Ann Noninvasive Electrocardiol; 2020 Sep; 25(5):e12763. PubMed ID: 32329134
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Histogram Analysis of Native T
    Wu CW; Wu R; Shi RY; An DA; Chen BH; Jiang M; Bacyinski A; Rahim A; Deen JM; Hu J; Han TT; Xu JR; Wu LM
    J Magn Reson Imaging; 2019 Mar; 49(3):668-677. PubMed ID: 30142234
    [TBL] [Abstract][Full Text] [Related]  

  • 25. T1 measurements identify extracellular volume expansion in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy.
    Ho CY; Abbasi SA; Neilan TG; Shah RV; Chen Y; Heydari B; Cirino AL; Lakdawala NK; Orav EJ; González A; López B; Díez J; Jerosch-Herold M; Kwong RY
    Circ Cardiovasc Imaging; 2013 May; 6(3):415-22. PubMed ID: 23549607
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Myocardial Perfusion Defects in Hypertrophic Cardiomyopathy Mutation Carriers.
    Hughes RK; Camaioni C; Augusto JB; Knott K; Quinn E; Captur G; Seraphim A; Joy G; Syrris P; Elliott PM; Mohiddin S; Kellman P; Xue H; Lopes LR; Moon JC
    J Am Heart Assoc; 2021 Aug; 10(15):e020227. PubMed ID: 34310159
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regional Stress-Induced Ischemia in Non-fibrotic Hypertrophied Myocardium in Young HCM Patients.
    Jablonowski R; Fernlund E; Aletras AH; Engblom H; Heiberg E; Liuba P; Arheden H; Carlsson M
    Pediatr Cardiol; 2015 Dec; 36(8):1662-9. PubMed ID: 26066352
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The relationship between the quantitative extent of late gadolinium enhancement and burden of nonsustained ventricular tachycardia in hypertrophic cardiomyopathy: A delayed contrast-enhanced magnetic resonance study.
    Weissler-Snir A; Hindieh W; Spears DA; Adler A; Rakowski H; Chan RH
    J Cardiovasc Electrophysiol; 2019 May; 30(5):651-657. PubMed ID: 30680853
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical significance of global two-dimensional strain as a surrogate parameter of myocardial fibrosis and cardiac events in patients with hypertrophic cardiomyopathy.
    Saito M; Okayama H; Yoshii T; Higashi H; Morioka H; Hiasa G; Sumimoto T; Inaba S; Nishimura K; Inoue K; Ogimoto A; Shigematsu Y; Hamada M; Higaki J
    Eur Heart J Cardiovasc Imaging; 2012 Jul; 13(7):617-23. PubMed ID: 22271116
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Late Gadolinium Enhancement in Patients With Hypertrophic Cardiomyopathy and Preserved Systolic Function.
    Mentias A; Raeisi-Giglou P; Smedira NG; Feng K; Sato K; Wazni O; Kanj M; Flamm SD; Thamilarasan M; Popovic ZB; Lever HM; Desai MY
    J Am Coll Cardiol; 2018 Aug; 72(8):857-870. PubMed ID: 30115224
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Left Atrial Mechanical Function and Global Strain in Hypertrophic Cardiomyopathy.
    Kim KJ; Choi HM; Yoon YE; Kim HL; Lee SP; Kim HK; Kim YJ; Cho GY; Zo JH; Sohn DW
    PLoS One; 2016; 11(6):e0157433. PubMed ID: 27336444
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Associations between perfusion defects, tissue changes and myocardial deformation in hypertrophic cardiomyopathy, uncovered by a cardiac magnetic resonance segmental analysis.
    Garcia Brás P; Aguiar Rosa S; Thomas B; Fiarresga A; Cardoso I; Pereira R; Branco G; Cruz I; Baquero L; Cruz Ferreira R; Mota Carmo M; Rocha Lopes L
    Rev Port Cardiol; 2022 Jul; 41(7):559-568. PubMed ID: 36065775
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of losartan on left ventricular hypertrophy and fibrosis in patients with nonobstructive hypertrophic cardiomyopathy.
    Shimada YJ; Passeri JJ; Baggish AL; O'Callaghan C; Lowry PA; Yannekis G; Abbara S; Ghoshhajra BB; Rothman RD; Ho CY; Januzzi JL; Seidman CE; Fifer MA
    JACC Heart Fail; 2013 Dec; 1(6):480-7. PubMed ID: 24621999
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Myocardial fibrosis is associated with biventricular dysfunction in patients with hypertrophic cardiomyopathy.
    Prinz C; van Buuren F; Faber L; Bitter T; Bogunovic N; Burchert W; Horstkotte D
    Echocardiography; 2012 Apr; 29(4):438-44. PubMed ID: 22150531
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic implications of global myocardial mechanics in hypertrophic cardiomyopathy by cardiovascular magnetic resonance feature tracking. Relations to left ventricular hypertrophy and fibrosis.
    Hinojar R; Fernández-Golfín C; González-Gómez A; Rincón LM; Plaza-Martin M; Casas E; García-Martín A; Fernandez-Mendez MA; Esteban A; Nacher JJJ; Zamorano JL
    Int J Cardiol; 2017 Dec; 249():467-472. PubMed ID: 29121751
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diastolic dysfunction assessed by cardiac magnetic resonance imaging tissue tracking on normal-thickness wall segments in hypertrophic cardiomyopathy.
    Qiao J; Zhao P; Lu J; Huang L; Ma X; Zhou X; Xia L
    BMC Med Imaging; 2023 Jan; 23(1):7. PubMed ID: 36624416
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypertrophic obstructive cardiomyopathy complicated with acute myocardial infarction and diffuse fibrosis: surgery or not?
    Wang Y; Zhao X; Zhai M; Huang Y; Zhou Q; Zhang Y; Mao Y; Zhang J
    BMC Cardiovasc Disord; 2022 Apr; 22(1):168. PubMed ID: 35418024
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early marker of regional left ventricular deformation in patients with hypertrophic cardiomyopathy evaluated by MRI tissue tracking: The effects of myocardial hypertrophy and fibrosis.
    Xu HY; Chen J; Yang ZG; Li R; Shi K; Zhang Q; Liu X; Xie LJ; Jiang L; Guo YK
    J Magn Reson Imaging; 2017 Nov; 46(5):1368-1376. PubMed ID: 28370909
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Strain echocardiography is related to fibrosis and ventricular arrhythmias in hypertrophic cardiomyopathy.
    Haland TF; Almaas VM; Hasselberg NE; Saberniak J; Leren IS; Hopp E; Edvardsen T; Haugaa KH
    Eur Heart J Cardiovasc Imaging; 2016 Jun; 17(6):613-21. PubMed ID: 26873460
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differences in the extent of fibrosis in obstructive and nonobstructive hypertrophic cardiomyopathy.
    Avegliano G; Politi MT; Costabel JP; Kuschnir P; Trivi M; Ronderos R
    J Cardiovasc Med (Hagerstown); 2019 Jun; 20(6):389-396. PubMed ID: 30994509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.